Question

What is the recovery time after stem cell therapy for Spinal Muscular Atrophy?

An infusion may have a short procedural recovery, but it does not imply motor-neuron recovery. SMA requires ongoing respiratory, nutritional, orthopaedic and rehabilitation monitoring, and established therapy must not be delayed for an unproven intervention.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

What the evidence shows for Spinal Muscular Atrophy

The evidence and regulatory status of approved SMA medicines cannot be transferred to a stem-cell product. NINDS describes approved disease-modifying options including nusinersen and onasemnogene abeparvovec, alongside multidisciplinary respiratory, nutritional and rehabilitation care. See the NINDS SMA overview. Any cell proposal should identify its product, genetic rationale, protocol, age and disease-stage criteria, comparator and interaction with established treatment.

Am I a candidate? → · Spinal Muscular Atrophy: full overview → · Spinal Muscular Atrophy cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information